Ownership history in BARCLAYS PLC · 4 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in LAKESHORE BIOPHARMA CO LTD (LSB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 24,757 | — | 0% | 0.00% | $18K | — |
| 2025 Q2 | UNCHANGED | 24,757 | — | 0% | 0.00% | $25K | — |
| 2025 Q1 | UNCHANGED | 24,757 | — | 0% | 0.00% | $61K | — |
| 2024 Q4 | INITIATED | 24,757 | — | — | 0.00% | $86K | — |